Cargando…
The right place for IL-1 inhibition in COVID-19
Autores principales: | Cavalli, Giulio, Dagna, Lorenzo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7826019/ https://www.ncbi.nlm.nih.gov/pubmed/33493449 http://dx.doi.org/10.1016/S2213-2600(21)00035-7 |
Ejemplares similares
-
The course of action for effective anti-cytokine treatment in COVID-19
por: Cavalli, Giulio, et al.
Publicado: (2021) -
IL-1 and IL-6 inhibition affects the neutralising activity of anti-SARS-CoV-2 antibodies in patients with COVID-19
por: Della-Torre, Emanuel, et al.
Publicado: (2021) -
Cutaneous vasculitis following COVID-19 vaccination
por: Cavalli, Giulio, et al.
Publicado: (2021) -
The conundrum of interleukin-6 blockade in COVID-19
por: Campochiaro, Corrado, et al.
Publicado: (2020) -
Granulocyte-macrophage colony stimulating factor in COVID-19: friend or foe?
por: Mehta, Puja, et al.
Publicado: (2021)